Yishan Niu

Yishan Niu

Auto-generated profile, based on publicly available information

Yishan Niu

Department of General Surgery, Central Hospital, Tianjin University (The Third Central Hospital of Tianjin), Tianjin, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2024 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
YNYishan Niu
Yishan Niu
XYXiaoye Yuan
Xiaoye Yuan
FGFansheng Guo
Fansheng Guo
JCJinglin Cao
Jinglin Cao
YWYang Wang
Yang Wang
QZQiang Zeng
Qiang Zeng
Background: This investigation evaluated the prognostic significance of the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), and introduced a combined NLR-PLR score to evaluate the correlation between NLR-PLR score and hepatocellular carcinoma (HCC) recurrence. Material/Methods: We enrolled 110 patients who underwent orthotopic liver transplantation (LT) for HCC. The neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) were assessed, and appropriate cut-off values were established. The NLR-PLR score ranged from 0 to 2 as follows: score of 2, high NLR (≥ 3.37) and high PLR (≥ 105.96); score of 1, either high NLR or high PLR; score of 0, neither high NLR nor high PLR. Results: The median overall survival (OS) of patients with NLR-PLR score of 0, 1 and 2 was 27, 26.5, and 6 months, respectively. The median OS of patients with NLR-PLR score of 2 was shorter than those with 0 (P < 0.001) and 1 (P < 0.001). The median disease-free survival (DFS) time of patients with NLR-PLR score of 0, 1 and 2 was 24.5, 24, and 6 months, The median DFS of patients with NLR-PLR score of 2 was shorter than those with 0 (P = 0.001) and 1 (P = 0.015). Multivariate analysis showed that NLR-PLR score was an independent risk factor for prognosis and survival. Conclusion: NLR, PLR and NLR-PLR score can predict the long-term survival of patients, and NLR-PLR score, having more predictive value than NLR and PLR alone is an independent risk factor for patient survival. more predictive value than NLR and PLR alone.

22 October 2025 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
CLChun-Wei Li
Chun-Wei Li
QLQi Li
Qi Li
YLYu Liu
Yu Liu
YZYu Zhang
Yu Zhang
ZWZhong-Kui Wang
Zhong-Kui Wang
KYKang Yu
Kang Yu
Ectopic fat distribution reflects patient’s metabolic profile, shaping the tumor microenvironment, which may be a key prognostic indicator. Our study pursues to explore the independent and combined effects of muscle atrophy and abnormal fat distribution on survival in gastric cancer patients. This retrospective cohort study analyzed body composition in 283 gastric cancer patients from Center Hospital, Tianjin University (June 2016–May 2025) using pretreatment CT at L3, assessing muscle mass, intermuscular, and visceral fat. Ectopic fat phenotypes included visceral obesity (increased visceral adipose tissue, VAT) and myosteatosis (reduced skeletal muscle density, SMD). Associations between body composition parameters/phenotypes and progression-free survival (PFS), overall survival (OS), and cachexia-related survival (CRS) were evaluated using Kaplan–Meier analysis with log-rank tests and Cox proportional hazards regression. Of the 283 patients, 32 patients (11.3%) were BMI-define obese, 139 patients (49.1%) showed visceral obesity, and 176 patients (62.2%) presented with myosteatosis. Sarcopenia was present in 234 patients (82.7%), and 151 patients (53.4%) presented with a combination of sarcopenia and myosteatosis. During a median follow-up of 41 months (2–108 months), 53 patients developed metastasis, 6 relapse, and 142 died. Skeletal muscle mass (Normal Attenuation Muscle Area, NAMA, HR = 0.989, 95% CI 0.980–0.998, P = 0.022, for PFS) and quality (SMD, HR = 0.975, 95% CI 0.955–0.995, P = 0.013, for PFS) serve as protective prognostic factors after multiple covariate adjustments. Multivariate analyses identified all adiposity-related parameters, including Low Attenuation Muscle Area (LAMA, HR = 1.015, 95% CI 1.003–1.026, P = 0.012, for PFS), intermuscular adipose tissue (IMAT, HR = 1.018, 95% CI 1.002–1.034, P = 0.027, for PFS), and VFI (HR = 1.008, 95% CI 1.001–1.015, P = 0.042) as negative indicators for survival. Sensitivity analyses confirmed these associations. Besides, IMAT, LAMA, and VFI significantly influence prognosis in advanced patients (TNM stage III–IV). Kaplan–Meier survival analysis revealed sarcopenic visceral obesity markedly reduces survival; when combined with myosteatosis (SMVO), this combined phenotype further exacerbated CRS (5-year CRS: 74.7% in SMVO, P = 0.019) beyond the effects of individual phenotypes. Sarcopenic obesity (myosteatosis/visceral obesity) can identify poorer prognosis in gastric cancer patients, especially male patients. It is crucial for obese gastric cancer patients to evaluate their body composition, specifically focusing on fat distribution. Trial registration: Registered in August 2016, NCT02873676 at www.clinicaltrials.gov .

10 April 2023 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
QZQiang Zeng
Qiang Zeng
JCJinglin Cao
Jinglin Cao
YNYishan Niu
Yishan Niu
XZXin Zhao
Xin Zhao
YWYang Wang
Yang Wang
QZQiang Zeng
Qiang Zeng
Background: This study aimed to determine whether altered mRNA, long non-coding RNA, and circular RNA expression is related to hepatocellular carcinoma recurrence after liver transplantation. Methods: Five recurrent and 5 non-recurrent primary hepatocellular carcinoma samples were used to perform RNA sequencing. Then, differentially expressed mRNAs, differentially expressed long non-coding RNAs, and differentially expressed circular RNAs between recurrent group and non-recurrent group were identified. In addition, differentially expressed long non-coding RNA/differentially expressed circular RNA–differentially expressed mRNA co-expression network, and competing endogenous RNA (differentially expressed circular RNA/differentially expressed long non-coding RNA–miRNA–differentially expressed mRNA) regulatory network were constructed. Finally, real-time quantitative polymerase chain reaction was performed for verification. Results: Five hundred forty-one differentially expressed mRNAs, 239 differentially expressed long non-coding RNAs, and 16 differentially expressed circular RNAs in the recurrent group were obtained. Gene set enrichment analysis indicated that these differentially expressed mRNAs may affect hepatocellular carcinoma recurrence through multiple pathways, such as E2F, epithelial–mesenchymal transition, G2M, and oxidative phosphorylation. Then, 993 differentially expressed long non-coding RNA–differentially expressed mRNA co-expression pairs and 28 differentially expressed circular RNA/differentially expressed mRNA co-expression pairs were obtained. The competing endogenous RNA network contained 10 circular RNA–miRNA pairs, 12 long non-coding RNA–miRNA pairs, and 36 miRNA– mRNA pairs. Real-time quantitative polymerase chain reaction results showed the same expression trend as RNA-seq results. Conclusion: Our results reveal key mRNAs, long non-coding RNAs, and circular RNAs associated with recurrence in hepatocellular carcinoma patients after liver transplantation Cite this article as: Zeng Q, Cao J, Niu Y, et al. Identification of recurrence-related mRNAs and noncoding RNAs in hepatocellular carcinoma following liver transplantation. Turk J Gastroenterol. 2023;34(4):394-405.